Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
D001943:Breast Neoplasms / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced; D003875:Drug Eruptions; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006393:Hemangiopericytoma / Q000188:drug therapy; D006801:Humans; D007263:Infusions, Parenteral; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D013280:Stomatitis / Q000139:chemically induced; D013997:Time Factors; D014565:Urogenital Neoplasms / Q000188:drug therapy
D005467:Floxuridine